Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

Charles H. Adler; Stewart A. Factor; Mitchell Brin; Kapil Dev Sethi

doi:10.1002/mds.10001

Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

Charles H. Adler, Stewart A. Factor, Mitchell Brin, Kapil Dev Sethi

Neurology

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

Original language	English (US)
Pages (from-to)	158-161
Number of pages	4
Journal	Movement Disorders
Volume	17
Issue number	1
DOIs	https://doi.org/10.1002/mds.10001
State	Published - Jan 1 2002

Keywords

Botulinum toxin
Immunoresistance
Oromandibular dystonia

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/mds.10001

Cite this

@article{2005d86647f3473ab412f92571c70b20,

title = "Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia",

abstract = "Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.",

keywords = "Botulinum toxin, Immunoresistance, Oromandibular dystonia",

author = "Adler, {Charles H.} and Factor, {Stewart A.} and Mitchell Brin and Sethi, {Kapil Dev}",

year = "2002",

month = jan,

day = "1",

doi = "10.1002/mds.10001",

language = "English (US)",

volume = "17",

pages = "158--161",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

AU - Adler, Charles H.

AU - Factor, Stewart A.

AU - Brin, Mitchell

AU - Sethi, Kapil Dev

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

AB - Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

KW - Botulinum toxin

KW - Immunoresistance

KW - Oromandibular dystonia

UR - http://www.scopus.com/inward/record.url?scp=0036461016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036461016&partnerID=8YFLogxK

U2 - 10.1002/mds.10001

DO - 10.1002/mds.10001

M3 - Article

C2 - 11835455

AN - SCOPUS:0036461016

SN - 0885-3185

VL - 17

SP - 158

EP - 161

JO - Movement Disorders

JF - Movement Disorders

IS - 1

ER -

Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this